Bioequivalence and Safety of Twice‐Daily Sustained‐Release Paracetamol (Acetaminophen) Compared With 3‐ and 4‐Times‐Daily Paracetamol: A Repeat‐Dose, Crossover Pharmacokinetic Study in Healthy Volunteers

Twice‐daily sustained‐release (SR) paracetamol (acetaminophen) offers convenient administration to chronic users. This study investigated at steady state (during the last 24 hours of a 3‐day dosing period) the pharmacokinetics, bioequivalence, and safety of twice‐daily SR paracetamol compared with e...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Dongzhou J., Collaku, Agron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084369/
https://www.ncbi.nlm.nih.gov/pubmed/28815997
http://dx.doi.org/10.1002/cpdd.369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084369/
https://www.ncbi.nlm.nih.gov/pubmed/28815997
http://dx.doi.org/10.1002/cpdd.369

Ejemplares similares